Author:
Reinert Siegmar,Neff Andreas
Reference85 articles.
1. Adeberg, S., Akbaba, S., Lang, K., Held, T., Verma, V., Nikoghosyan, A., Bernhardt, D., Münter, M., Freier, K., Plinkert, P., Hauswald, H., Herfarth, K., Rieken, S., Debus, J., Jensen, A.D.: The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck. Int J Radiat Oncol Biol Phys 1;106(1):167–173 (2020).
2. Akuamoa-Boateng, E.: Die Wirkung fraktionierter Kobalt-60-Gamma-Bestrahlung auf die Glandula parotis zur Entstehung der radiogenen Xerostomie. Med. Habil. -Schrift, Bochum 1987.
3. Barnes L., Eveson J. W., Reichart P., Sidransky D.: Pathology and Genetics of Head and Neck Tumours, WHO IARC Press, Lyon (2005).
4. Barzan L., Pin M.: Extra-capsular dissection in benign parotid tumors. Oral Oncol, 2012; 48: 977–979 (2012).
5. Batsakis, J.G., Luna, M.A.: Histopathologic grading of salivary gland neoplasms: I. Mucoepidermoid carcinomas. Ann Otol Rhinol Laryngol 99, 835 (1990).